Molecule Details
| InChIKey | BCZUAADEACICHN-UHFFFAOYSA-N |
|---|---|
| Compound Name | Sgx-523 |
| Canonical SMILES | Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.14 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB06314 |
|---|---|
| Drug Name | SGX-523 |
| CAS Number | 1022150-57-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | A MET receptor tyrosine kinase inhibitor. |
Cross-references: BindingDB: 60589 ChEBI: 90624 CHEMBL1236107 ChemSpider: 24608644 PDB: SX8 ZINC: ZINC000039129916
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08581 | MET | Hepatocyte growth factor receptor | inhibitor | targets |